We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-14.27%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$123B
AUM Growth
-$24.7B
(-17%)
Cap. Flow
-$418M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
30.06%
Holding
304
New
10
Increased
88
Reduced
149
Closed
13
Avg Time Held
3.8
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$485M |
| 2 |
Hess
HES
|
+$460M |
| 3 |
Wells Fargo
WFC
|
+$356M |
| 4 |
Albemarle
ALB
|
+$291M |
| 5 |
Linde
LIN
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$468M |
| 2 |
Dell
DELL
|
+$283M |
| 3 |
Adobe
ADBE
|
+$261M |
| 4 |
Praxair Inc
PX
|
+$231M |
| 5 |
NetApp
NTAP
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 25.96% |
| 3 | Industrials | 15.66% |
| 4 | Financials | 9.32% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.12T
| $5.86B | 4.74% |
50,603,456
-4,188,112
| -8% | -$468M |
2013 Q2
22 quarters
|
|
|
2
Adobe
ADBE
$97.9B
| $4.49B | 3.64% |
19,849,680
-1,082,425
| -5% | -$261M |
2013 Q2
22 quarters
|
|
3
Biogen
BIIB
$34.8B
| $4.43B | 3.59% |
14,716,217
-157,579
| -1% | -$50.3M |
2013 Q2
22 quarters
|
|
4
Microsoft
MSFT
$4.01T
| $3.93B | 3.18% |
38,651,173
-1,166,462
| -3% | -$125M |
2013 Q2
22 quarters
|
|
5
Amgen
AMGN
$235B
| $3.86B | 3.13% |
19,846,216
-947,226
| -5% | -$185M |
2013 Q2
22 quarters
|
|
6
Southwest Airlines
LUV
$20B
| $3.43B | 2.78% |
73,760,183
-195,705
| -0.3% | -$10.4M |
2013 Q2
22 quarters
|
|
7
United Airlines
UAL
$32.9B
| $3.2B | 2.6% |
38,257,977
-117,636
| -0.3% | -$10.3M |
2013 Q2
22 quarters
|
|
8
Texas Instruments
TXN
$255B
| $3.18B | 2.57% |
33,615,175
-260,954
| -0.8% | -$25.3M |
2013 Q2
22 quarters
|
|
9
FedEx
FDX
$69.9B
| $2.43B | 1.97% |
15,060,682
-41,302
| -0.3% | -$8.74M |
2013 Q2
22 quarters
|
|
10
Alphabet (Google) Class A
GOOGL
$4.27T
| $2.29B | 1.86% |
43,885,860
-1,434,220
| -3% | -$77.5M |
2015 Q3
13 quarters
|
|
11
JPMorgan Chase
JPM
$891B
| $2.26B | 1.83% |
23,155,278
-81,125
| -0.3% | -$8.64M |
2015 Q1
15 quarters
|
|
12
American Airlines Group
AAL
$8.13B
| $2.21B | 1.79% |
68,904,981
-40,000
| -0.1% | -$1.39M |
2013 Q4
20 quarters
|
|
13
Alphabet (Google) Class C
GOOG
$4.22T
| $2.2B | 1.78% |
42,460,060
-1,842,800
| -4% | -$98.6M |
2013 Q2
22 quarters
|
|
14
AstraZeneca
AZN
$259B
| $2.13B | 1.73% |
28,073,963
+374,320
| +1% | +$29.2M |
2015 Q3
13 quarters
|
|
|
15
NetApp
NTAP
$42.2B
| $2.11B | 1.71% |
35,431,378
-2,687,546
| -7% | -$193M |
2013 Q2
22 quarters
|
|
|
16
Wells Fargo
WFC
$248B
| $2.1B | 1.7% |
45,468,779
+6,956,592
| +18% | +$356M |
2013 Q2
22 quarters
|
|
17
Alibaba
BABA
$276B
| $2.09B | 1.7% |
15,267,130
-66,520
| -0.4% | -$9.83M |
2014 Q3
17 quarters
|
|
18
Sony
SONY
$144B
| $2.02B | 1.63% |
208,917,020
-6,609,100
| -3% | -$69.9M |
2013 Q2
22 quarters
|
|
19
Novartis
NVS
$286B
| $1.96B | 1.59% |
25,542,150
+720,389
| +3% | +$56.1M |
2013 Q2
22 quarters
|
|
20
Micron Technology
MU
$1.05T
| $1.84B | 1.49% |
57,864,885
-240,750
| -0.4% | -$9.13M |
2013 Q2
22 quarters
|
|
21
Boston Scientific
BSX
$64B
| $1.59B | 1.29% |
45,062,777
+294,992
| +0.7% | +$10.7M |
2013 Q2
22 quarters
|
|
22
Delta Air Lines
DAL
$51.4B
| $1.42B | 1.15% |
28,455,026
-99,985
| -0.4% | -$5.44M |
2013 Q2
22 quarters
|
|
23
Qualcomm
QCOM
$191B
| $1.37B | 1.11% |
24,000,322
+2,306,140
| +11% | +$140M |
2013 Q2
22 quarters
|
|
24
Charles Schwab
SCHW
$163B
| $1.31B | 1.06% |
31,531,241
-386,259
| -1% | -$17.5M |
2013 Q2
22 quarters
|
|
25
HP
HPQ
$27.8B
| $1.27B | 1.03% |
62,229,738
-212,400
| -0.3% | -$4.95M |
2013 Q2
22 quarters
|
|
Similar funds
Primecap Management's Q4 2018 Portfolio in Review
As of Q4 2018, Primecap Management held 304 positions worth $123B, down 17% from $148B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2018 filing shows 10 new, 88 increased, 149 reduced and 13 closed positions. Its largest new stake was Linde: 1,431,369 shares worth $223M. The largest sale was Eli Lilly, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2018 buy was Linde: 1,431,369 shares worth $223M.
- Primecap Management added most to Bank of America in Q4 2018, an estimated $485M increase.
- Primecap Management's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $468M.
- Primecap Management fully exited Praxair Inc in Q4 2018, selling an estimated $231M.
- Primecap Management's ten largest holdings make up 30% of its $123B portfolio in Q4 2018.
- Primecap Management opened 10 new positions and closed 13 in Q4 2018.
- Primecap Management's portfolio value fell 17% quarter-over-quarter to $123B.
Based on Primecap Management's 13F filing for Q4 2018, filed 12 Feb 2019.